The development of the number of cases in the inpatient sector of the German health system proves that there is an increased implementation of OS in the context of hysterectomy for benign indications, despite the current lack of recommendation from specialist societies. In a survey of German gynecologists, which we conducted together with the North-East German Society for Gynecological Oncology (NOGGO e.V.) and the Ovary Commission of the Working Group for Gynecological Oncology (AGO e.V.), confirms the acceptance and frequent use of OS (manuscript forthcoming). Carrying out an OS could be favored by the increase in laparoscopic interventions with access to tubes (laparoscopic + laparoscope-assisted vaginal hysterectomies; 2005: 10%, 2020: 57%), with a decrease in purely transvaginal hysterectomies (2005: 50%; 2020: 21%) (German Federal Office of Statistics). From our point of view, an adjustment of the expert consensus recommendations in Germany and other countries is necessary in order to give the practicing physicians a secure basis for this procedure, which is now very frequently performed (for comparison: 49 697 appendectomies in 2020). We recommend an interdisciplinary agreement on a uniform approach to counseling, indication, and implementation of OS, as well as for the histopathological work-up for detecting precursor lesions of ovarian carcinoma. Existing data from clinical studies and routine documentation regarding the clinical benefits, risks, and the health-economic balance of OS should be evaluated and collected in a prospective national register in the future. Women seeking permanent contraception should be informed about the advantages and disadvantages of salpingectomy.
Ingo B. Runnebaum, Angela Kather, Jalid Sehouli
Department of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University, Jena, Germany (Runnebaum, Kather),
[email protected]
Department of Gynecology with Oncological Surgery, Charit�Universit�tsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany (Sehouli)
Conflict of interest statement
The authors declare that no conflict of interest exists.
Manuscript received on 29 March 2022, revised version accepted on 12 May 2022
Translated from the original German by Veronica A. Raker, PhD.
Cite this as:
Runnebaum IB, Kather A, Sehouli J: Opportunistic salpingectomy for the primary prevention of ovarian cancer. Dtsch Arztebl Int 2022; 119: 846�7. DOI: 10.3238/arztebl.m2022.0232
| 1. | Zentrum f�r Krebsregisterdaten: Eierstockkrebs (Ovarialkarzinom). www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Eierstockkrebs/eierstockkrebs_node.html (last accessed on 7 February 2022). |
| 2. | Falconer H, Yin L, Gr�nberg H, Altman D: Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst 2015; 107(2). |
| 3. | Kurman RJ, Shih IM: The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010; 34: 433�43. CrossRef MEDLINE PubMed Central |
| 4. | Vorwergk J, Radosa MP, Nicolaus K, et al.: Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J Cancer Res Clin Oncol 2014; 140: 859�65 CrossRef MEDLINE |
| 5. | Ntoumanoglou-Schuiki A, Tomasch G, Laky R, Taumberger N, Bjelic-Radisic V, Tamussino K: Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: what do national societies advise? Eur J Obstet Gynecol Reprod Biol 2018; 225: 110�2 CrossRef MEDLINE |